Vera Ribeiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Vera Ribeiro has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Isa Cavaco
Institute of Biotechnology and Bioengineering, Center of Molecular and Structural Biomedicine, University of Algarve
10 shared publications - José Pedro Gil
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet , Solna
7 shared publications Maria Celeste Lechner
Laboratorio de Bioquimica, Instituto Gulbenkian de Ciencia, Oeiras Aapartado 14, 2781, Portugal
4 shared publications- Ana Luisa Ribeiro
Family Medicine, ACeS Alto Tâmega e Barroso, Chaves, Portugal
3 shared publications - Isabel Cavaco
Universidade do Algarve
3 shared publications - João Costa Pessoa
Centro Química Estrutural, Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal
3 shared publications
Latest Publications
- Open Access
- 1 December 2015
- Published by Elsevier in Molecular Metabolism
- Vol. 4 (12) , 891-902
Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
- 1 December 2015
- Published by Elsevier in Molecular Metabolism
- Vol. 4 (12) , 891-902
Open AccessBioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
- 1 June 2015
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 147, 165-176
The effect of phosphate on the nuclease activity of vanadium compounds
- 1 June 2015
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 147, 165-176
The effect of phosphate on the nuclease activity of vanadium compounds
- Open Access
- 12 January 2015
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 13 (10) , 2866-2869
Cucurbiturils as supramolecular inhibitors of DNA restriction by type II endonucleases
Cucurbiturils inactivate the restriction reaction of type II endonucleases via supramolecular interactions. This was monitored for different enzyme–DNA combinations in the absence and presence of organic macrocycles. The process can be re-activated by competitive displacement on addition of polyamines.
- 12 January 2015
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 13 (10) , 2866-2869
Open AccessCucurbiturils as supramolecular inhibitors of DNA restriction by type II endonucleases
Cucurbiturils inactivate the restriction reaction of type II endonucleases via supramolecular interactions. This was monitored for different enzyme–DNA combinations in the absence and presence of organic macrocycles. The process can be re-activated by competitive displacement on addition of polyamines.
- 1 October 2013
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 14 (9) , 969-975
Drug Metabolism and Transport Under Hypoxia
Tumour progression is characterized by a rapid cell growth accompanied by changes in the microenvironment, largely due to hypoxia. The angiogenic switch involves changes in the expression of genes that play key roles in tumour progression, invasion, metastasis and therapeutic response, contributing to tumour aggressiveness. The effect of hypoxia on the cellular concentrations of drug metabolizing enzymes and transporters is much less understood. A brief summary of the signaling mechanisms triggered by hypoxia is presented, followed by a review of the known effects of hypoxia on drug metabolism and transport. Most of the studies available have focused on Cytochromes P450 and ATP-binding cassette transporters, while influx transporters of the SLC family have been less investigated. Given its potential to contribute both to the understanding of the pathogenesis of disease and to the optimization of therapeutics, it is rather surprising that this area of research is still underdeveloped. An increasing number of studies focusing on this subject are bound to provide key information for drug development and optimization of therapeutics.
- 1 October 2013
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 14 (9) , 969-975
Drug Metabolism and Transport Under Hypoxia
Tumour progression is characterized by a rapid cell growth accompanied by changes in the microenvironment, largely due to hypoxia. The angiogenic switch involves changes in the expression of genes that play key roles in tumour progression, invasion, metastasis and therapeutic response, contributing to tumour aggressiveness. The effect of hypoxia on the cellular concentrations of drug metabolizing enzymes and transporters is much less understood. A brief summary of the signaling mechanisms triggered by hypoxia is presented, followed by a review of the known effects of hypoxia on drug metabolism and transport. Most of the studies available have focused on Cytochromes P450 and ATP-binding cassette transporters, while influx transporters of the SLC family have been less investigated. Given its potential to contribute both to the understanding of the pathogenesis of disease and to the optimization of therapeutics, it is rather surprising that this area of research is still underdeveloped. An increasing number of studies focusing on this subject are bound to provide key information for drug development and optimization of therapeutics.
- 1 June 2013
- Vol. 33 (6) , 2549-2555
Lack of Relevance of HIF-1 alpha Polymorphisms in Breast Cancer in a Portuguese Population
We aimed to study the prevalence of Hypoxia inducible factor-1 alpha (HIF-1 alpha) P582S and A588T polymorphisms in a Portuguese breast cancer population and its effect on the transcriptional activity of HIF-1 alpha in MCF7 breast adenocarcinoma cells. We performed a polymerase chain Reaction - restriction fragment length polymorphism (PCR-RFLP)-based genotyping of a Portuguese breast cancer population for two HIF-1 alpha polymorphisms. Furthermore, by site-directed muta genesis, we generated a variant form of HIF-1 alpha and compared its transcriptional activity with the wild-type HIF-1 alpha in MCF7 cells. There were no significant differences in genotypic frequencies for P582S and A588T between breast cancer patients and controls, nor between the transcriptional activity of the 582S mutant and the wild-type HIF-1 alpha. In conclusion, there is no association between HIF-1 alpha polymorphisms and incidence of breast cancer in the Portuguese examined population. Furthermore, the P582S mutation does not affect transcriptional activity of HIF-1 alpha in breast cancer cells, contrary to previous findings in other cell lines, suggesting that the impact of this mutation is cell-type specific.
- 1 June 2013
- Vol. 33 (6) , 2549-2555
Lack of Relevance of HIF-1 alpha Polymorphisms in Breast Cancer in a Portuguese Population
We aimed to study the prevalence of Hypoxia inducible factor-1 alpha (HIF-1 alpha) P582S and A588T polymorphisms in a Portuguese breast cancer population and its effect on the transcriptional activity of HIF-1 alpha in MCF7 breast adenocarcinoma cells. We performed a polymerase chain Reaction - restriction fragment length polymorphism (PCR-RFLP)-based genotyping of a Portuguese breast cancer population for two HIF-1 alpha polymorphisms. Furthermore, by site-directed muta genesis, we generated a variant form of HIF-1 alpha and compared its transcriptional activity with the wild-type HIF-1 alpha in MCF7 cells. There were no significant differences in genotypic frequencies for P582S and A588T between breast cancer patients and controls, nor between the transcriptional activity of the 582S mutant and the wild-type HIF-1 alpha. In conclusion, there is no association between HIF-1 alpha polymorphisms and incidence of breast cancer in the Portuguese examined population. Furthermore, the P582S mutation does not affect transcriptional activity of HIF-1 alpha in breast cancer cells, contrary to previous findings in other cell lines, suggesting that the impact of this mutation is cell-type specific.
- Open Access
- 1 January 2011
- Published by Medknow in Journal of Pharmacy and Bioallied Sciences
- Vol. 3 (3) , 453-9
Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism
It is well known that drug disposition and response are greatly determined by the activities of drug metabolizing enzymes, which are polymorphic. Some of these polymorphisms are clinically relevant and presented an ethnic-dependent pattern of distribution. The characterization of the genetic distribution of different populations allows the selection of therapeutic options in accordance with the genetic background, with the objective to avoid adverse reactions and inefficacy of the treatment. In this work, we studied selected genetic polymorphisms in drug metabolizing enzymes in three different ethnic groups - Portugal, Mozambique and Colombia. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) genotyping methods were developed for drug metabolizing enzymes, namely, cholesterol 7α-hydroxylase (CYP7A1) (−203A>C, −346C>T, −496C>T, N233S, G347S), sterol 27-hydroxylase (CYP27A1) (R164W, A169V, D273N, V400A) and oxysterol 7α-hydroxylase (CYP7B1) (−116C>G, R324H, 1774C>T) to characterize the allelic distribution of these polymorphisms among three different ethnic/geographic origins. A total of 12 CYP7A1, CYP27A1 and CYP7B1 genetic variants were genotyped in a sample of 92 Portuguese, 151 Mozambican and 91 Colombian subjects. The variants N233S in CYP7A1 and 1774C>T in CYP7B1 were not detected in any population studied. The promoter polymorphisms in CYP7A1 (−203A>C, −346C>T, −496C>T) had high frequency in the three ethnic groups. G347S (CYP7A1), R164W, A169V and V400A (CYP27A1) were present in a low frequency but with a similar distribution in the three ethnic groups. Significant differences were observed for D273N (CYP27A1), −346C>T (CYP7A1), −116C>G and R324H (CYP7B1)Our results demonstrate a high variability of drug metabolizing enzymes between the different populations analyzed, indicating that at least some of these polymorphisms are ethnic specific.
- 1 January 2011
- Published by Medknow in Journal of Pharmacy and Bioallied Sciences
- Vol. 3 (3) , 453-9
Open AccessEthnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism
It is well known that drug disposition and response are greatly determined by the activities of drug metabolizing enzymes, which are polymorphic. Some of these polymorphisms are clinically relevant and presented an ethnic-dependent pattern of distribution. The characterization of the genetic distribution of different populations allows the selection of therapeutic options in accordance with the genetic background, with the objective to avoid adverse reactions and inefficacy of the treatment. In this work, we studied selected genetic polymorphisms in drug metabolizing enzymes in three different ethnic groups - Portugal, Mozambique and Colombia. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) genotyping methods were developed for drug metabolizing enzymes, namely, cholesterol 7α-hydroxylase (CYP7A1) (−203A>C, −346C>T, −496C>T, N233S, G347S), sterol 27-hydroxylase (CYP27A1) (R164W, A169V, D273N, V400A) and oxysterol 7α-hydroxylase (CYP7B1) (−116C>G, R324H, 1774C>T) to characterize the allelic distribution of these polymorphisms among three different ethnic/geographic origins. A total of 12 CYP7A1, CYP27A1 and CYP7B1 genetic variants were genotyped in a sample of 92 Portuguese, 151 Mozambican and 91 Colombian subjects. The variants N233S in CYP7A1 and 1774C>T in CYP7B1 were not detected in any population studied. The promoter polymorphisms in CYP7A1 (−203A>C, −346C>T, −496C>T) had high frequency in the three ethnic groups. G347S (CYP7A1), R164W, A169V and V400A (CYP27A1) were present in a low frequency but with a similar distribution in the three ethnic groups. Significant differences were observed for D273N (CYP27A1), −346C>T (CYP7A1), −116C>G and R324H (CYP7B1)Our results demonstrate a high variability of drug metabolizing enzymes between the different populations analyzed, indicating that at least some of these polymorphisms are ethnic specific.
- 1 October 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1804 (10) , 2036-2045
Analysis of binding modes of ligands to multiple conformations of CYP3A4
- 1 October 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1804 (10) , 2036-2045
Analysis of binding modes of ligands to multiple conformations of CYP3A4
- Open Access
- 19 May 2010
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 312
Plasmodium infection alters Anopheles gambiae detoxification gene expression
Background: Anopheles gambiae has been shown to change its global gene expression patterns upon Plasmodium infection. While many alterations are directly related to the mosquito's innate immune response, parasite invasion is also expected to generate toxic by-products such as free radicals. The current study aimed at identifying which loci coding for detoxification enzymes are differentially expressed as a function of Plasmodium berghei infection in midgut and fat body tissues. Results: Using a custom-made DNA microarray, transcript levels of 254 loci primarily belonging to three major detoxification enzyme families (glutathione S-transferases, cytochrome P450 monooxygenases and esterases) were compared in infected and uninfected mosquitoes both during ookinete invasion and the release of sporozoites into the hemocoel. The greatest changes in gene expression were observed in the midgut in response to ookinete invasion. Interestingly, many detoxification genes including a large number of P450s were down-regulated at this stage. In the fat body, while less dramatic, gene expression alterations were also observed and occurred during the ookinete invasion and during the release of sporozoites into the hemocoel. While most gene expression changes were tissue-related, CYP6M2, a CYP previously associated with insecticide resistance, was over-expressed both in the midgut and fat body during ookinete invasion. Conclusions: Most toxicity-related reactions occur in the midgut shortly after the ingestion of an infected blood meal. Strong up-regulation of CYP6M2 in the midgut and the fat body as well as its previous association with insecticide resistance shows its broad role in metabolic detoxification.
- 19 May 2010
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 312
Open AccessPlasmodium infection alters Anopheles gambiae detoxification gene expression
Background: Anopheles gambiae has been shown to change its global gene expression patterns upon Plasmodium infection. While many alterations are directly related to the mosquito's innate immune response, parasite invasion is also expected to generate toxic by-products such as free radicals. The current study aimed at identifying which loci coding for detoxification enzymes are differentially expressed as a function of Plasmodium berghei infection in midgut and fat body tissues. Results: Using a custom-made DNA microarray, transcript levels of 254 loci primarily belonging to three major detoxification enzyme families (glutathione S-transferases, cytochrome P450 monooxygenases and esterases) were compared in infected and uninfected mosquitoes both during ookinete invasion and the release of sporozoites into the hemocoel. The greatest changes in gene expression were observed in the midgut in response to ookinete invasion. Interestingly, many detoxification genes including a large number of P450s were down-regulated at this stage. In the fat body, while less dramatic, gene expression alterations were also observed and occurred during the ookinete invasion and during the release of sporozoites into the hemocoel. While most gene expression changes were tissue-related, CYP6M2, a CYP previously associated with insecticide resistance, was over-expressed both in the midgut and fat body during ookinete invasion. Conclusions: Most toxicity-related reactions occur in the midgut shortly after the ingestion of an infected blood meal. Strong up-regulation of CYP6M2 in the midgut and the fat body as well as its previous association with insecticide resistance shows its broad role in metabolic detoxification.
- 22 December 2009
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 5 (6) , 273-277
Ethnic variability of HIF-1α polymorphisms
The hypoxia-inducible factor -1α (HIF-1α) is a transcription factor that plays a crucial role in the cellular response to hypoxia. The C1772T (P582S) and G1790A (A588T) polymorphisms, within the oxygen dependent degradation domain of HIF-1α protein,
- 22 December 2009
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 5 (6) , 273-277
Ethnic variability of HIF-1α polymorphisms
The hypoxia-inducible factor -1α (HIF-1α) is a transcription factor that plays a crucial role in the cellular response to hypoxia. The C1772T (P582S) and G1790A (A588T) polymorphisms, within the oxygen dependent degradation domain of HIF-1α protein,
- 1 April 2009
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 103 (4) , 622-632
DNA cleavage activity of VIVO(acac)2 and derivatives
- 1 April 2009
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 103 (4) , 622-632
DNA cleavage activity of VIVO(acac)2 and derivatives